Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary
Journal of Oncology Practice · 2018-04 · 14 (4) · 247-249
DOI: 10.1200/jop.18.00005 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Oncology Practice, 2018-04. Verfasst von Julie R Brahmer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins Kimmel Cancer Center, Baltimore, MD; American Society of Clinical Oncology, Alexandria, VA; University of Washington; and Fred Hutchins…. Die Arbeit wurde bisher 266-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Johns Hopkins Kimmel Cancer Center, Baltimore, MD; American Society of Clinical Oncology, Alexandria, VA; University of Washington; and Fred Hutchinson Cancer Research Center, Seattle, WA.
Zitieren
APA
Brahmer, J. R., Lacchetti, C., & Thompson, J. A. (2018). Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary. Journal of Oncology Practice, 14(4), 247-249. https://doi.org/10.1200/jop.18.00005
Vancouver
Brahmer JR, Lacchetti C, Thompson JA. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary. Journal of Oncology Practice. 2018;14(4):247-249. doi:10.1200/jop.18.00005
BibTeX
@article{Brahmer2018,
author = {Brahmer, Julie R and Lacchetti, Christina and Thompson, John A},
title = {Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary},
journal = {Journal of Oncology Practice},
year = {2018},
volume = {14},
number = {4},
pages = {247--249},
doi = {10.1200/jop.18.00005}
}
EUVIMED